Month: March 2022

Invesco Ltd.: Form 8.3 – Workspace Group Plc

Written by Customer Service on March 9, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION (a) Full name of discloser: Invesco Ltd. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Workspace Group PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Landsbankinn hf.: Annual General Meeting 23 March 2022

Written by Customer Service on March 9, 2022. Posted in Public Companies.

The Annual General Meeting of Landsbankinn hf. will be held virtually on Wednesday 23 March 2022 at 16:00. Enclosed is the agenda for the Annual General Meeting. Further information about the meeting is available on the Bank´s website, landsbankinn.is/en/the-bank/investor-relations/agms For further information:Hanna K. Thoroddsen, Investor Relations, ir@landsbankinn.isRúnar Pálmason, Public Relations, pr@landsbankinn.is AttachmentAgenda AGM 2022

Ebix Reports Record Revenues of $994.9 Million, GAAP Diluted EPS of $2.22

Written by Customer Service on March 9, 2022. Posted in Earnings Releases And Operating Results.

JOHNS CREEK, Ga., March 09, 2022 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of on-demand software and e-commerce services to the insurance, financial services, travel, healthcare and e-learning industries, today reported fiscal 2021 fourth quarter (“Q4 2021”) and full year results for the periods ended December 31, 2021. Ebix will host a conference call to review its results today at 11:00 a.m. EST (details below). Ebix Chairman, President and CEO Robin Raina said, “The results of 2021 were impacted adversely by COVID-19 for 12 months, while the results of 2020 were impacted adversely by the pandemic for a period of 10 months. Despite that, the Company is reporting operating income of $119 million with revenues approaching a billion dollars in the year 2021. Q4 2021 revenues grew 39% sequentially...

Assertio Reports Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 9, 2022. Posted in Earnings Releases And Operating Results.

$32.2 Million Fourth Quarter Net Product Sales, a 7% Increase from Fourth Quarter 2020 and $109.4 Million Full Year Net Product Sales $17.8 Million Fourth Quarter Non-GAAP Adjusted EBITDA, a 118% Increase from Fourth Quarter 2020 and $48.8 Million Full Year Non-GAAP Adjusted EBITDA Provides 2022 Net Product Sales Guidance Range of $126.0 Million to $136.0 Million and 2022 Non-GAAP Adjusted EBITDA Guidance Range of $64.0 Million to $72.0 Million Completed Acquisition of Otrexup® (methotrexate) LAKE FOREST, Ill., March 09, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a corporate update. Fourth...

Consolidated Water Declares Second Quarter Cash Dividend

Written by Customer Service on March 9, 2022. Posted in Dividend Reports And Estimates.

GEORGE TOWN, Cayman Islands, March 09, 2022 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and operator of advanced water supply and treatment plants, today announced that its board of directors has approved a quarterly cash dividend of $0.085 per share. The cash dividend is payable April 29, 2022 to shareholders of record at the close of business on April 1, 2022. About Consolidated Water Co. Ltd.Consolidated Water Co. Ltd. develops and operates advanced water supply and treatment plants and water distribution systems. The company operates water production facilities in the Cayman Islands, The Bahamas and the British Virgin Islands and operates water treatment facilities in the United States. The company also manufactures and services a wide range of products and provides...

Resolutions of the Annual General Meeting of Evli Bank Plc held on 9 March 2022

Written by Customer Service on March 9, 2022. Posted in Public Companies.

EVLI BANK PLC STOCK EXCHANGE RELEASE 9 MARCH 2022 AT 15.30 (EET/EEST) Evli Bank Plc’s Annual General Meeting on 9 March 2022 approved the financial statements and discharged the members of the Board of Directors and the company’s CEO from liability for the financial year 2021. The Meeting approved the Board of Directors’ proposal to pay a dividend of EUR 1.06 per share for total amount of EUR 25,288,883.20 for the financial year. The dividend is paid to shareholders who are registered in the shareholders’ register maintained by Euroclear Finland Oy on the dividend record date on 11 March 2022. The dividend is paid on 18 March 2022. The Annual General Meeting approved the Remuneration Report 2021 of the company’s governing bodies. Board of Directors The company’s extraordinary general meeting held on 22 December 2021 resolved,...

BBS Bioactive Bone Substitutes Plc has filed the CE-marking application of Artebone® bone void filler to the authorities

Written by Customer Service on March 9, 2022. Posted in Public Companies.

BBS-Bioactive Bone Substitutes Plc, Company Release, Inside Information, March 9, 2022 at 3:30 p.m. BBS Bioactive Bone Substitutes Plc has filed the CE-marking application of Artebone® bone void filler to the authorities BBS-Bioactive Bone Substitutes Plc has today on March 9 submitted to the authorities the application for the CE marking of the Artebone® bone filler substitute. CEO Ilkka Kangasniemi: “I am very pleased that today we have submitted to the authorities the CE marking application for the Artebone® bone void filler. This has been our company’s top priority and our employees have worked tremendously to achieve it. Our work will now continue during the approval process as we complete process validations and audits carried out by the authorities. In addition, we will provide answers to any possible additional questions...

Gluten Free Food Market to Worth $9.99 Billion by 2021-2028 | Gluten Free Food Industry CAGR of 8.29%

Written by Customer Service on March 9, 2022. Posted in Mergers And Acquisitions.

Companies covered in gluten free food market are The Kraft Heinz Company (Illinois, U.S.), The Hain Celestial Group Inc. (New York, U.S.), General Mills Inc. (Minnesota, U.S.), Kellogg’s Company (Michigan, U.S.), Conagra Brands, Inc. (Illinois, U.S.), Barilla G.E.R Fratelli S.P.A (Parma, Italy), Noumi Limited (Australia), Enjoy Life Foods (Mondelez International) (Illinois, U.S.), Alara Wholefoods Ltd. (London, U.K.), Prima Foods Ltd. (South Wales, U.K.) and more players profiled. Pune, India, March 09, 2022 (GLOBE NEWSWIRE) — The global gluten-free food market size was valued at USD 5.25 billion in 2020. The market is estimated to grow from USD 5.72 billion in 2021 to USD 9.99 billion in 2028, exhibiting a CAGR of 8.29% during the forecast period. The increasing popularity of the product’s benefits, rising demand for functional...

Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting

Written by Customer Service on March 9, 2022. Posted in Public Companies.

AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that two posters have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting, which is being held April 8-13, 2022 at the Ernest N. Morial Convention Center in New Orleans, Louisiana. The first poster will highlight preclinical data from the company’s GADLEN™ platform, while the second will highlight preclinical data from SL-9258 (TIGIT-Fc-LIGHT), derived from the company’s ARC® platform, demonstrating its ability to broaden the activity of checkpoint inhibitors...

MedMira receives the CE mark for its Reveal® TP (Syphilis) and starts clinical trials in Canada

Written by Customer Service on March 9, 2022. Posted in Public Companies.

HALIFAX, Nova Scotia, March 09, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) launches its Reveal® TP (Syphilis) product in Europe and gets clinical trials underway in Canada. The Company received the CE mark today and is now available in Europe and any countries accepting the CE mark. Furthermore, the Company continues their work on the Investigational Testing Application (ITA) for the planned clinical trial in Canada to start in the spring with the support and partnership of REACH Nexus (www.reachnexus.ca) at the MAP Centre for Urban Health Solutions (www.maphealth.ca), housed at St. Michael’s Hospital of Unity Health Toronto. Syphilis is a sexually transmitted blood-borne infections (STBBIs) caused by the bacterium Treponema pallidum. When left untreated syphilis moves to the tertiary stage causing the re-occurrence...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals